Results
64
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
64 companies
PharmaEngine
Market Cap: NT$9.6b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$66.90
7D
1.1%
1Y
-24.6%
Fidson Healthcare
Market Cap: ₦98.5b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦42.90
7D
3.6%
1Y
172.4%
Exelixis
Market Cap: US$11.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$40.09
7D
2.7%
1Y
50.4%
AstraZeneca Pharma India
Market Cap: ₹233.1b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,324.70
7D
5.7%
1Y
25.5%
Consun Pharmaceutical Group
Market Cap: HK$14.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$17.27
7D
8.1%
1Y
124.6%
AGP
Market Cap: PK₨55.5b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨198.09
7D
-0.7%
1Y
74.9%
CytomX Therapeutics
Market Cap: US$540.9m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$3.30
7D
13.8%
1Y
187.0%
Puma Biotechnology
Market Cap: US$262.9m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.13
7D
6.0%
1Y
93.6%
BioStem Technologies
Market Cap: US$84.7m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$4.96
7D
-0.2%
1Y
-49.9%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.5b
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م154.00
7D
11.2%
1Y
323.1%
Catalyst Pharmaceuticals
Market Cap: US$2.6b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.84
7D
6.8%
1Y
4.2%
Merck
Market Cap: US$223.6b
Operates as a healthcare company worldwide.
MRK
US$89.19
7D
13.5%
1Y
-18.7%
Blue Jet Healthcare
Market Cap: ₹115.1b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹663.35
7D
2.7%
1Y
34.5%
JW Lifescience
Market Cap: ₩195.1b
Provides national infusion solutions in South Korea and internationally.
A234080
₩12,600.00
7D
2.9%
1Y
14.9%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س11.0b
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
4015
ر.س156.60
7D
2.0%
1Y
-10.1%
Hoechst Pakistan
Market Cap: PK₨38.4b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,983.07
7D
0.2%
1Y
89.7%
TTY Biopharm
Market Cap: NT$19.6b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$78.70
7D
1.3%
1Y
7.2%
Lupin
Market Cap: ₹900.7b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹1,972.00
7D
2.7%
1Y
-10.3%
Harmony Biosciences Holdings
Market Cap: US$1.5b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$27.28
7D
-0.8%
1Y
-21.2%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹463.3b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,735.10
7D
2.4%
1Y
-0.5%
ChemoMetec
Market Cap: DKK 11.8b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 678.00
7D
9.0%
1Y
76.0%
WuXi AppTec
Market Cap: CN¥329.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥112.03
7D
8.9%
1Y
114.0%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.5b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م700.18
7D
2.8%
1Y
190.4%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥16.1b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥65.73
7D
0.2%
1Y
-14.1%
Sanjivani Paranteral
Market Cap: ₹2.8b
Operates as a pharmaceutical company in India.
531569
₹227.70
7D
-1.8%
1Y
-26.6%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.7b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹221.34
7D
3.0%
1Y
26.8%
L&C BIOLTD
Market Cap: ₩1.2t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩49,850.00
7D
-0.7%
1Y
148.0%
HBM Holdings
Market Cap: HK$12.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$15.33
7D
9.4%
1Y
922.0%
Medpace Holdings
Market Cap: US$15.1b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$532.49
7D
7.2%
1Y
55.2%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م3.3b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م223.38
7D
2.2%
1Y
164.7%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.80
7D
3.6%
1Y
44.4%
ADMA Biologics
Market Cap: US$3.5b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$14.66
7D
-6.1%
1Y
-27.7%
RPG Life Sciences
Market Cap: ₹37.5b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,269.70
7D
-1.5%
1Y
-13.0%
Abbott India
Market Cap: ₹636.3b
Operates as a pharmaceutical company in India.
500488
₹29,944.10
7D
0.6%
1Y
6.6%
BioSyent
Market Cap: CA$130.2m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.98
7D
1.9%
1Y
8.9%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.3b
Produces and sells medicines in China.
600285
CN¥21.92
7D
-1.2%
1Y
-11.5%